# Juliann Chmielecki

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/juliann-chmielecki/

## Facts

| Field | Value |
| --- | --- |
| Citations | 23,985 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 57 |
| i10-index | 91 |
| Last Known Institution | AstraZeneca (United States) |
| OpenAlex ID | https://openalex.org/A5063661642 |
| ORCID iD | https://orcid.org/0009-0001-1113-0164 |
| Works | 376 |

## Researcher papers

- [Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden](https://scholariq.org/papers/analysis-of-100-000-human-cancer-genomes-reveals-the-landscape-of-tumor/)
- [Activation of MET via Diverse Exon 14 Splicing Alterations Occurs in Multiple Tumor Types and Confers Clinical Sensitivity to MET Inhibitors](https://scholariq.org/papers/activation-of-met-via-diverse-exon-14-splicing-alterations-occurs-in-multiple/)
- [Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Lung Cancer: Distinct Natural History of Patients with Tumors Harboring the T790M Mutation](https://scholariq.org/papers/acquired-resistance-to-egfr-tyrosine-kinase-inhibitors-in-egfr-mutant-lung/)
- [Osimertinib in Patients With Epidermal Growth Factor Receptor Mutation–Positive Non–Small-Cell Lung Cancer and Leptomeningeal Metastases: The BLOOM Study](https://scholariq.org/papers/osimertinib-in-patients-with-epidermal-growth-factor-receptor-mutation-positive/)
- [Mechanisms of acquired resistance to first-line osimertinib: Preliminary data from the phase III FLAURA study](https://scholariq.org/papers/mechanisms-of-acquired-resistance-to-first-line-osimertinib-preliminary-data/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [RNA modifications and cancer](https://scholariq.org/topics/rna-modifications-and-cancer/)
- [Sarcoma Diagnosis and Treatment](https://scholariq.org/topics/sarcoma-diagnosis-and-treatment/)
- [Tumors and Oncological Cases](https://scholariq.org/topics/tumors-and-oncological-cases-2/)

## Researcher university

- [AstraZeneca (United States)](https://scholariq.org/institutions/astrazeneca-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.